×
About 33,888 results

ALLMedicine™ Severe Acute Respiratory Syndrome Center

Research & Reviews  12,148 results

SARS-CoV-2 and Guillain-Barré Syndrome: Lessons from Viral Infections.
https://doi.org/10.1089/vim.2021.0187
Viral Immunology; Meidaninikjeh S, Sabouni N et. al.

Jun 30th, 2022 - Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is responsible for the COVID-19 pandemic. COVID-19 has a broad clinical spectrum from asymptomatic patients to multiorgan dysfunction and septic shock. Most of the common symptoms of COV...

Immunogenicity of Third-dose BNT162b2 mRNA Vaccine Following Two Doses of ChAdOx1 in He...
https://doi.org/10.3343/alm.2022.42.6.688
Annals of Laboratory Medicine; Kim JA, Bang HI et. al.

Jun 30th, 2022 - Following the original severe acute respiratory syndrome coronavirus 2 strain (Wuhan-Hu-1) in December 2019, the Delta variant in May 2021 and the Omicron variant in December 2021 were classified as variants of concern. The pandemic has been ongoi...

BNT162b2 Vaccine Effectiveness against Omicron in Children 5 to 11 Years of Age.
https://doi.org/10.1056/NEJMoa2205011
The New England Journal of Medicine; Cohen-Stavi CJ, Magen O et. al.

Jun 30th, 2022 - Limited evidence is available on the real-world effectiveness of the BNT162b2 vaccine against coronavirus disease 2019 (Covid-19) and specifically against infection with the omicron variant among children 5 to 11 years of age. Using data from the ...

Dementia prevalence, a contextual factor associated with SARS-CoV-2 in veterans affairs...
https://doi.org/10.1111/jgs.17945
Journal of the American Geriatrics Society; Bayer TA, DeVone F et. al.

Jun 30th, 2022 - Alzheimer's disease and related dementias (ADRD) impact the diagnosis and infection control of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in nursing homes (NH) by influencing the behavior of residents and their caregivers. Health...

Immune Responses after a Third Dose of mRNA Vaccine Differ in Virus-Naive versus SARS-C...
https://doi.org/10.2215/CJN.00830122
Clinical Journal of the American Society of Nephrology : ... Attias P, Azzaoui I et. al.

Jun 29th, 2022 - After two doses of mRNA vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), patients on dialysis show a defective humoral response, but a third dose could increase anti-SARS-CoV-2 spike IgG titers. Responses could be diff...

see more →

Guidelines  51 results

Ambient air pollution and COVID-19 risk: Evidence from 35 observational studies
https://www.sciencedirect.com/science/article/pii/S0013935121013608?via=ihub
Environmental Research; Zang ST, .

Mar 30th, 2022 - Coronavirus disease 2019 (COVID-19) is induced by a previously undiscovered coronavirus, designated as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Lu et al., 2020). Since SARS-CoV-2 was first discovered in December 2019, as of Ap...

Duration of Infectious Virus Shedding by SARS-CoV-2 Omicron Variant–Infected Vaccines
https://wwwnc.cdc.gov/eid/article/28/5/22-0197_article
Emerging Infectious Diseases; Takahash K, Ishikane M et. al.

Mar 15th, 2022 - To determine virus shedding duration, we examined clinical samples collected from the upper respiratory tracts of persons infected with severe acute respiratory syndrome coronavirus 2 Omicron variant in Japan during November 29–December 18, 2021. ...

SARS-CoV-2 Omicron Variant Neutralization after mRNA-1273 Booster Vaccination
https://www.nejm.org/doi/full/10.1056/NEJMc2119912?query=featured_home
The New England Journal of Medicine; Pajon R, .

Jan 26th, 2022 - The highly transmissible omicron (B.1.1.529) variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is of mounting concern globally. The omicron variant carries a large number of spike mutations, including at least 15 mutations in...

Homologous and Heterologous Covid-19 Booster Vaccinations
https://www.nejm.org/doi/full/10.1056/NEJMoa2116414?query=featured_home
The New England Journal of Medicine; Atmar RL, .

Jan 26th, 2022 - In the United States, the significant efficacy of three candidate vaccines — mRNA-1273 (Moderna), Ad26.COV2.S (Johnson & Johnson–Janssen), and BNT162b2 (Pfizer–BioNTech) — against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) result...

Nervous system consequences of COVID-19
https://www.science.org/doi/10.1126/science.abm2052
Science Spudich S, Nath A.

Jan 20th, 2022 - Although severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is considered a respiratory pathogen, myriad neurologic complications—including confusion, stroke, and neuromuscular disorders—manifest during acute COVID-19. Furthermore, malad...

see more →

Drugs  29 results see all →

Clinicaltrials.gov  817 results

COVID-19 Associated Lymphopenia Pathogenesis Study in Blood
https://clinicaltrials.gov/ct2/show/NCT04401436

Jun 24th, 2022 - Coronavirus disease 2019 (COVID-19) is an acute respiratory syndrome caused by the novel coronavirus severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). The emergence of SARS-CoV-2 has led to a pandemic with a wide range of manifestation...

Send-In Sample Collection for Comprehensive Analyses of Innate and Adaptive Immune Responses During Acute COVID-19 and Convalescence
https://clinicaltrials.gov/ct2/show/NCT04582903

Jun 24th, 2022 - In response to the public health emergency posed by the coronavirus disease 2019 (COVID-19) pandemic, researchers at the National Institute of Allergy and Infectious Diseases (NIAID) are leading a large international collaboration to characterize ...

Natural History of Systemic and Nasal Mucosal Immunity to Influenza and SARS-CoV-2 in Adults After Vaccination
https://clinicaltrials.gov/ct2/show/NCT04794829

Jun 24th, 2022 - Title: Natural History of Systemic and Nasal Mucosal Immunity to Influenza and SARS-CoV-2 in Adults after Vaccination Study Description: Yearly influenza vaccination is necessary due to short-lasting influenza immunity and changing strains of circ...

Low-dose Naltrexone for Post-COVID Fatigue Syndrome
https://clinicaltrials.gov/ct2/show/NCT05430152

Jun 24th, 2022 - There is a growing number of individuals who do not recover to previous levels of health and function following an acute infection by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), but rather develop what has been referred to as 'Lo...

Admission and Management of Occupational or Other Exposures to Biodefense/Bioterrorism Agents or to Epidemic/Emerging Infectious Diseases
https://clinicaltrials.gov/ct2/show/NCT01200953

Jun 24th, 2022 - Since the fall 2001 distribution of letters containing Bacillus anthracis spores via the US postal system, increased attention has been paid to the evaluation and management of bioterrorism-related illness. Similarly, the emergence of Severe Acute...

see more →

News  488 results

Fast Five Quiz: COVID-19 Vaccines
https://www.medscape.com/viewarticle/958940

Jun 17th, 2022 - Editor's Note: The information in this quiz is current as of 6/17/2022. For the most recent COVID information, see https://www.medscape.com/resource/coronavirus As of June 2022, there have been 527,211,631 confirmed cases of COVID-19 and 6,289,371...

Fast Five Quiz: COVID-19 Variants
https://www.medscape.com/viewarticle/975321

Jun 16th, 2022 - Editor's Note: The information in this quiz is current as of 6/16/2022. For the most recent COVID information, see https://www.medscape.com/resource/coronavirus As of June 2022, nearly 6.3 million deaths worldwide were directly attributed to coron...

Effect of dupilumab on SARS-CoV-2 antibody response in atopic dermatitis
https://www.mdedge.com/dermatology/article/254041/atopic-dermatitis/effect-dupilumab-sars-cov-2-antibody-response-atopic

Apr 25th, 2022 - Key clinical point: Dupilumab lowered SARS-CoV-2 immunoglobulin G (IgG) antibody levels in unvaccinated patients with atopic dermatitis (AD) and COVID-19 infection; however, it did not impair antibody response in mRNA vaccinated patients with AD.

What placental mechanisms protect the fetus from harm in the setting of maternal COVID-19 infection?
https://www.mdedge.com/obgyn/article/253625/obstetrics/what-placental-mechanisms-protect-fetus-harm-setting-maternal-covid
Lydia L. Shook, MD

Apr 8th, 2022 - Taglauer ES, Wachman EM, Juttukonda L, et al. Acute severe acute respiratory syndrome coronavirus 2 infection in pregnancy is associated with placental angiotensin-converting enzyme 2 shedding.

Ambient air pollution and COVID-19 risk: Evidence from 35 observational studies
https://www.sciencedirect.com/science/article/pii/S0013935121013608?via=ihub
Environmental Research; Zang ST, .

Mar 30th, 2022 - Coronavirus disease 2019 (COVID-19) is induced by a previously undiscovered coronavirus, designated as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Lu et al., 2020). Since SARS-CoV-2 was first discovered in December 2019, as of Ap...

see more →

Patient Education  22 results see all →